Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Rang in aandelen #40615
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Aandeelprijs
$0.13607016
Laatst gesynchroniseerd: 2024-09-10
Marktkapitalisatie
$112.29K
Verandering (1 dag)
22.46%
Verandering (1 jaar)
0.00%
Land
GB
Handel BiVictriX Therapeutics Plc (BVX)

Categorie

Dividendrendementgeschiedenis voor BiVictriX Therapeutics Plc (BVX)
Het dividendrendement (TTM) van BiVictriX Therapeutics Plc (aandelsymbool: BVX) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van BiVictriX Therapeutics Plc (BVX) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten